Recent Advances in Drug Synthesis and Drug Discovery
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 124
Special Issue Editor
Interests: virtual screening; drug discovery; small molecular inhibitors against intrinsic disorder proteins; phase separation and aggregation; ionotropic glutamate receptors channel; membrane-protein association
Special Issue Information
Dear Colleagues,
This Special Issue aims to bring together researchers and practitioners, offering unprecedented opportunities for innovation and therapeutic development. This scope encompasses cutting-edge methodologies, technologies and strategies for the synthesis and discovery of novel drugs across various areas such as structural bioinformatics, drug design, computational and molecular cell biology. In drug discovery, interdisciplinary approaches involving computational biology, artificial intelligence, high-throughput screening and structural biology are the major areas, potentially aiding in the identification of potential drug candidates, target validation and optimization of drug-like properties. Recent findings from CRISPR-Cas9 gene editing, small molecule targeting RNA and peptide therapeutics also provide novel approach for drug development. Indeed, targeting biomolecular condensates provides a new strategy for potential therapeutic intervention against neurodegenerative diseases.
We invite and welcome high-quality original research articles that report on novel and significant findings on inhibitors targeting protein, RNA, lipid, etc.
Dr. Ramesh Prasad
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular docking
- high-throughput virtual screening
- computer-aided small molecular drug discovery
- machine learning for advancing computational chemistry
- molecular dynamics simulation
